DRMA · Dermata Therapeutics, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of DRMA in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns DRMA
13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 151,868 | 3.78% |
| Insiders (Forms 3, 4, 5) | 633,967 | 15.76% |
| 13D/G-only blocks | 679,220 | 16.89% |
| Remaining | 2,557,088 | 63.58% |
| Registered funds (N-PORT, not summed) | 20,101 | 0.50% |
Shares outstanding: 4,022,143, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of DRMA
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
414,064 | ||
| 2 |
PROEHL GERALD T
Insider
CIK 1279191 · Aug 16, 2026
Director, President, CEO and Chairman, 10% Owner, issuer-wide
|
372,615 | ||
| 2.1 |
PROEHL GERALD T
13D
CIK 1279191 · Unknown · Feb 19, 2026
Item 4 purpose: not restated by this amendment, the earlier 13D's purpose stands
not summed
|
694,687 | ||
| 3 |
|
232,463 | ||
| 3.1 |
Kyri K. Van Hoose
13D
CIK 1860885 · Unknown · May 27, 2026
Item 4 purpose: Passive investment
not summed
|
384,352 | ||
| 4 |
|
211,246 | ||
| 5 |
ARMISTICE CAPITAL, LLC
13G
CIK 1601086 · Registered investment adviser · Dec 31, 2025
Rule 13d-1(b), qualified institution
|
53,910 | ||
| 6 |
GEODE CAPITAL MANAGEMENT, LLC
13F
CIK 1214717 · Registered investment adviser · Sep 30, 2026
|
20,101 | ||
| 7 |
Welch & Forbes LLC
13F
CIK 105495 · Registered investment adviser · Sep 30, 2026
|
20,000 | ||
| 8 |
|
19,695 | ||
| 9 |
Fidelity Extended Market Index Fund
Fund
S000006021 · Registered fund · Aug 31, 2026
Fidelity Concord Street Trust, not summed
|
18,995 | ||
| 10 |
|
18,747 | ||
| 11 |
UBS Group AG
13F
CIK 1610520 · Bank · Jun 30, 2026
Classes DRMA, DRMAW, carried, not yet filed for the newest quarter
|
18,600 | ||
| 12 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
CIK 1446194 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
15,989 | ||
| 13 |
XTX Topco Ltd
13F
CIK 1828301 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
14,787 | ||
| 14 |
BOOTHBAY FUND MANAGEMENT, LLC
13F
CIK 1549230 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
|
12,000 | ||
| 15 |
Virtu Financial LLC
13F
CIK 1533964 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
11,029 | ||
| 16 |
Advisory Alpha, LLC
13F
CIK 1576762 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
|
10,000 | ||
| 17 |
|
8,147 | ||
| 18 |
CITIGROUP INC
13F
CIK 831001 · Bank · Sep 30, 2026
|
6,625 | ||
| 19 |
Tower Research Capital LLC (TRC)
13F
CIK 1533421 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
3,860 | ||
| 20 |
Fidelity Series Total Market Index Fund
Fund
S000065248 · Registered fund · Aug 31, 2026
Fidelity Concord Street Trust, not summed
|
1,106 | ||
| 21 |
|
1,046 | ||
| 22 |
SBI Securities Co., Ltd.
13F
CIK 1851815 · Non-US institution · Sep 30, 2026
|
102 | ||
| 23 |
HIGHLINE WEALTH PARTNERS LLC
13F
CIK 2042654 · Registered investment adviser · Sep 30, 2026
|
26 | ||
| 24 |
MORGAN STANLEY
13F
CIK 895421 · Holding company · Jun 30, 2026
carried, not yet filed for the newest quarter
|
2 | ||
| 25 |
|
1 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.